Navigation Links
Keryx Biopharmaceuticals Receives Nasdaq Notification
Date:4/25/2008

NEW YORK, April 25 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today that it has received notice from The NASDAQ Stock Market ("Nasdaq") stating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued inclusion on the Nasdaq Global Market pursuant to Marketplace Rule 4450 (a)(5). This notification, which was received in a letter dated April 22, 2008, is a standard communication when the bid price of a Nasdaq-listed company closes below the minimum $1.00 per share requirement for 30 consecutive business days. The letter states that, in accordance with Marketplace Rule 4450(e)(2), the Company will be provided 180 calendar days to regain compliance by having the bid price of its common stock close at $1.00 per share or more for a minimum of 10 consecutive business days. The letter has no immediate effect on the listing of the Company's common stock at this time.

The Company plans to apply to transfer its listing to the Nasdaq Capital Market. If the Company's application to transfer its listing to the Nasdaq Capital Market is approved and the listing is transferred, the Company will be subject to the continued listing requirements of the Nasdaq Capital Market after such transfer, and no longer subject to the continued listing requirements of the Nasdaq Global Market. The Company's common stock will continue to trade on the Nasdaq Global Market until the transfer application has been reviewed and approved.

The Company currently meets the requirements for listing on the Nasdaq Capital Market, with the exception of the $1.00 minimum closing bid price requirement, although the Company cannot provide assurance that in the future it will continue to meet th
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
2. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
3. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
4. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
6. Keryx Biopharmaceuticals Announces Additions to Management Team
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
10. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
11. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...5 DSM Pharmaceutical Products toda...nce with Galenix, Saint Jean D,Illac, France, wher...acturing partner for Galenix commercial products o...borate on business development opportunities co-ma...on the strength of Galenix in drug product develop...
(Date:11/5/2009)... Nov. 5 ThermoGenesis Co...tive products for processing and storing adult ste...ter of fiscal 2010. ,, For the quarter ended Se... $5.2 million, a 15 percent increase over revenues...The Company said the key contributors to the growt...
(Date:11/5/2009)...Newswire-FirstCall/ -- Transgenomic, Inc. (OTC Bul...ts for the quarter ended September 30, 2009. The C...bles that follow. ,, Third Quarter 2009 ,,....01 per share for the third quarter of 2009 as com... for the third quarter of 2008. ,, Net sales w...
(Date:11/5/2009)... 5 Cepheid (Nasdaq: CPH...eaking at the following investor conferences, and ... Credit Suisse Healthcare Conferenc...ber, 2009 at 10 a.m. Mountain Time, ...nd, Tuesday, 1 December, 2009 at 1...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2
...ay, Apple,s Steve Jobs announced the new iPhone ...ut whenever you have something new come onto the m...Plus, you can,t compare Apples to oranges. In this...torola RAZRs, Nokias , Samsung , and all the ot...CNBC , Herb Greenberg, was very skeptical in sayin...
...Wis. - In a letter to members of Wisconsin,s Cong...to vote to lift president Bush,s restrictions on...ell Research Enhancement Act of 2007. , ,The Hous...asure on Jan. 11. , ,Doyle, who has supported prev... said the bill, also known as HR 3, would lift cur...
...Wis. - Responding to a lawsuit filed by Digene C...iolated a patent covering a single and rare type o...inue to develop products to detect high-risk infec...nfringing on claims of a U.S. patent - number 5,64...ted in Gaithersburg, Md., filed the suit in U.S. ...
Other Biology Technology:The Apple iPhone: A call to competitors 2The Apple iPhone: A call to competitors 3The Apple iPhone: A call to competitors 4Third Wave responds to Digene patent lawsuit 2
(Date:11/9/2009)... , Large blooms of tiny marine plants called phyt...eft exposed by the recent and rapid melting of ice...la. This remarkable colonisation is having a benef...back phytoplankton sinks to the sea-bed where it c.... , Reporting this week in the journal Global ...
(Date:11/9/2009)... , Cold Spring Harbor, N.Y. Oncologists have had...man cancers have mutations that disable a protein ...3 masterminds several cancer-fighting operations w...essively and often cannot be treated. , These t...suggests a new study from Cold Spring Harbor Labor...
(Date:11/9/2009)... , Rice University evolutionary biologists David ...hat high cooperation and low conflict between comp...g thing its "organismality," whether that thing is...Some of the traits scientists use to describe an o...in the same species, may not be necessary to achie...
Breaking Biology News(10 mins):Antarctica glacier retreat creates new carbon dioxide store 2CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3What is the meaning of 'one'? 2What is the meaning of 'one'? 3livethesource 28TM 29 Hosts Company Launch Event While Supporting The Brent Shapiro Foundations Annual Sober Night Out 57392 1livethesource 28TM 29 Hosts Company Launch Event While Supporting The Brent Shapiro Foundations Annual Sober Night Out 57392 2livethesource 28TM 29 Hosts Company Launch Event While Supporting The Brent Shapiro Foundations Annual Sober Night Out 57392 3Pesky fruit flies learn from experienced females 3A Study 9954 1Pesky fruit flies learn from experienced females 3A Study 9954 2Chloride found at levels that can harm aquatic life in urban streams of the Northern US 9949 1Chloride found at levels that can harm aquatic life in urban streams of the Northern US 9949 2
...demy of Sciences (NAS) will honor 13 individuals w...hievements in the areas of biology, chemistry, sol...leontology, social sciences, and psychology. , T...I MEDAL a medal and a prize of $20,000 as well as...ent,s choosing, awarded every three years to honor...
...spital announced today that it has been named an A...y (ASMBS) Bariatric Surgery Center of Excellence. ...izes surgical programs with a demonstrated track r... , This distinction recognizes the expertise of ...mitment to quality programs and services, says Rob...
...LEASE , From and for the heart, My Dear Valent...Chemistry , Wishing your Valentine good heart he...nsider the food some people love to hate, and hand...-shaped box of chocolates. Researchers in Connecti...ing broccoli may protect against heart disease. Th...
Other Biology News:Academy honors 13 for major contributions to science 2Academy honors 13 for major contributions to science 3Academy honors 13 for major contributions to science 4Academy honors 13 for major contributions to science 5Pennsylvania Hospital recognized for excellence in bariatric surgery 2American Chemical Society's Weekly PressPac -- Jan. 16, 2008 2American Chemical Society's Weekly PressPac -- Jan. 16, 2008 3American Chemical Society's Weekly PressPac -- Jan. 16, 2008 4American Chemical Society's Weekly PressPac -- Jan. 16, 2008 5American Chemical Society's Weekly PressPac -- Jan. 16, 2008 6American Chemical Society's Weekly PressPac -- Jan. 16, 2008 7American Chemical Society's Weekly PressPac -- Jan. 16, 2008 8American Chemical Society's Weekly PressPac -- Jan. 16, 2008 9
Chaperone Sampler Kit from BD Biosciences Pharmingen
SH3 Proteins II Sampler Kit from BD Biosciences Pharmingen
Mouse Anti-SOCS3 Monoclonal Antibody, Unconjugated, Clone SOC-25 from BioLegend
Caveolin Sampler Kit from BD Biosciences Pharmingen
Biology Products: